the aid library

LIST OPTIONS

Filter

9055

Health statistics in the Western Pacific Region 2023: monitoring health for the SDGs

World Health Organisation (WHO) (2024) CC

Health Statistics in the Western Pacific Region 2023: Monitoring health for the SDGs is the third biennial report providing an overview of the progress of the World Health Organization (‎WHO)‎ Western Pacific Region towards the health-related Sustainable Development Goal (‎SDG)‎ targets. Thi... more

Download (274)

View PDF (488)

Health in the green economy: Health Care Facilities

World Health Organization WHO (2021) C_WHO

WHO's Health in the Green Economy sector briefings examine the health impacts of climate change mitigation strategies considered by the Intergovernmental Panel on Climate Change in their Fourth Assessment Report.

Download (314)

View PDF (431)

Covid-19 RCCE Strategies for Cross-Border Movement in Eastern and Southern Africa

Social Science in Humanitarian Action (2020) CC

Key Considerations This brief focuses on cross-border movement in Eastern and Southern Africa (ESA) and its implications for development of risk communication and community engagement (RCCE) strategies aimed at preventing transmission of COVID-19 in the ESA region. Given the extensive risk of cross... more

Download (673)

View PDF (833)

A Comparison of Summary Measures of Quality of Service and Quality of Care for Family Planning in Haiti, Malawi, and Tanzania

Mallick, Lindsay, Wenjuan Wang, Temsah, Gheda (2017) C1

DHS Methodological Report No. 20

This study used Service Provision Assessment (SPA) and Demographic and Health Survey (DHS) data from Haiti, Malawi, and Tanzania to compare traditionally used additive methods with a data reduction method—principal component analysis (PCA).
We scored ... more

Download (395)

View PDF (490)

Accelerating salt reduction in Europe: a country support package to reduce population salt intake in the WHO European Region

World Health OrganizationEurope (2020) C_WHO

Excessive consumption of salt (more than 5 g per day) raises blood pressure, a major risk factor for cardiovascular diseases such as heart disease and stroke, and is the leading cause of death in the WHO European Region. Many countries in the Region have initiated national salt reduction strategies,... more

Download (285)

View PDF (275)

Elimination of human African trypanosomiasis as public health problem

World Health Organization WHO Team Control of Neglected Tropical Diseases (2022) C_WHO

More countries eliminate human African trypanosomiasis as a public health problem: Benin and Uganda (gambiense form) and Rwanda (rhodesiense form) Human African trypanosomiasis (HAT), or sleeping sickness, transmitted by tsetse flies in sub-Saharan Africa, is a life-threatening disease that afflict... more

Download (344)

View PDF (660)

Mapping of best community practices for accompanying eviction situations of refugees and migrants from Venezuela

R4V (2021) CC

This mapping of community experiences for the defense of the right to adequate housing in situations of risk of eviction or eviction in progress brings together practices and strategies used by families, collectives and community organizations that have different origins and interests in the region,... more

Download (838)

View PDF (1594)

Recovering from the Ebola Crisis: A summary report

UN Development Programme (2015)

In response to a call by the United Nations Secretary-General and the Governments of Guinea, Liberia and Sierra Leone, an international team conducted an Ebola Recovery Assessment.The aim was to contribute towards laying the foundation for short-, medium- and long-term recovery while the medical eme... more

Download (373)

View PDF (376)

Tool to assess impact of human resources for health investments on HIV, TB and malaria services and health outcomes

World Health Organization WHO (2022) C_WHO

The WHO Global strategy on human resources for health: workforce 2030 encourages development partners and global health initiatives to leverage their support to health systems in countries to sustainably strengthen the health workforce. To assess the impact of these investments, a methodology was de... more

Download (513)

View PDF (527)

Module: Psychoses

World Health Organization WHO (2015) C_WHO

Overview Learning objectives • Promote respect and dignity for people with psychoses. • Name common presentations of psychoses. • Name assessment principles of psychoses. • Name management principles of psychoses. • Perform an assessment for psychoses. • Use effective communicatio... more

Download (410)

View PDF (764)

North-west Syria: Cross-border Humanitarian Response Fact Sheet (october 2022)

Office for the Coordination of Humanitarian Affairs OCHA (2022) C1

An 82 percent funding gap is putting the lives of 2.5 million people in north-west Syria at risk this winter. The first cholera case in north-west Syria was confirmed on 19 September. See below for the latest updates. On 17 September, at least six airstrikes were reported in Idleb, 10 ... more

Download (277)

View PDF (301)

CARE Rapid Gender Analysis of COVID-19 in Myanmar

CARE (2020) CC

7 June 2020 Version 1 Women in Myanmar have traditionally been underrepresented in public decision-making processes, a trend which is continuing in structures established to respond to COVID-19. This means that even as women are disproportionately affected by the crisis, they have less say in how t... more

Download (1009)

View PDF (2055)

West and Central Africa: Humanitarian Bulletin, March 2015

UN Office for the Coordination of Humanitarian Affairs (2015)

USD$ 28 million allocated from UN Central Emergency Fund to assist people affected by Boko Haram’s insurgency. Boko Haram, insecurity exert misery in Cameroon’s Far North Region. Millions of people in Ebola-affected countries risk serious food shortages during the June-August lean ... more

Download (425)

View PDF (388)

Safety evaluation of certain contaminants in food: prepared by the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (‎JECFA)‎

World Health Organisation (WHO) (2023) C_WHO

This volume contains monographs prepared at the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which met virtually online from 1 to 12 February 2021. The detailed monographs in this volume summarize data on specific contaminants in food. Individual monographs ... more

Download (379)

View PDF (371)

Implementation of simultaneous diagnostic testing for COVID-19 and TB in high TB burden countries

Stop TB Partnership; WHO (2022) C_WHO

Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio... more

External Link

Environmental Determinants of Cardiovascular Disease

Bhatnagar, A. Circulation Research (2018) CC

Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu... more

Download (465)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1283)

View PDF (3858)

IASC Guidelines for mental health and psychosocial support in emergency settings
recommended

Inter-Agency Standing Committee (2007) C1

Specific action sheets offer useful guidance on mental health and psychosocial support and cover the following areas coordination assessment monitoring and evaluation protection and human rights standards human resources community mobilisation and support health services education dissemination of i... more

Download (235)

View PDF (371)

West Africa Desert Locust Crisis Appeal (May–December 2020)

Food and Agriculture Organization of the United Nations FAO; reliefweb (2020) C2

Recent forecasts by the Food and Agriculture Organization of the United Nations (FAO) have indicated a risk of locust invasion in West Africa from June 2020. From East Africa, some swarms could reach the eastern part of the Sahel and continue westwards from Chad to Mauritania. Surveillance and co... more

Download (747)

View PDF (763)

Water, Sanitation and Hygiene Manual

Norwegian Refugee Council; et al. (2015) C1

WASH Training for Hygiene Promotion Staff. This manual has been designed to train NRC hygiene promotion incentive staff on ... concept and importance of hygiene, diseases that are present or a risk in Kakuma Refugee. Camp and how to prevent them; monitoring WASH activities and prevention, managemen... more

IASC Guidelines for mental health and psychosocial support in emergency settings recommended

IASC Guidelines for mental health and psychosocial support in emergency settings
recommended